MedPath

NALOXONE HYDROCHLORIDE

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1971

Approved
Approval ID

6c9a1e1f-e324-405b-b578-41defae3c8ac

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 3, 2023

Manufacturers
FDA

Quality Care Products, LLC

DUNS: 831276758

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

naloxone hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code83008-007
Application NumberANDA211951
Product Classification
M
Marketing Category
C73584
G
Generic Name
naloxone hydrochloride
Product Specifications
Route of AdministrationNASAL
Effective DateMarch 3, 2023
FDA Product Classification

INGREDIENTS (6)

NALOXONE HYDROCHLORIDEActive
Quantity: 4 mg in 0.1 mL
Code: F850569PQR
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.